Lab4
Commercial- Indications
- Allergies, Atopic eczema
Company intelligence / Profile preview
Cultech Ltd manufactures and develops innovative nutritional supplements, especially probiotics and vitamin/mineral products. The company has ongoing preclinical research into the use of probiotics for reducing weight gain, inflammation, and cognitive decline linked to high-fat diets and Alzheimer's disease. It also collaborates on projects aimed at alleviating side effects from antibiotic treatments. Most products are already commercialized as food supplements; clinical development for new indications remains in early stages.[1][5]
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cultech Ltd.